Clinical Trials on High Sensitivity C-Reactive Protein in Russian Federation
Total 2 results
-
AstraZenecaTerminatedElevated High-sensitivity C-Reactive Protein (hsCRP)United States, Brazil, Bulgaria, Poland, Russian Federation, South Africa, United Kingdom, Germany, Estonia, Romania, Denmark, Netherlands, Norway, Canada, Mexico, Belgium, Israel, Puerto Rico, Colombia, Argentina, Venezuela, Panama, Urugu... and more
-
The S.N. Fyodorov Eye Microsurgery State InstitutionAlcon ResearchCompletedCorneal Astigmatism | Cataract Senile | Myopia, High-GradeRussian Federation